Anteris Technologies Global Corp
Anteris Technologies Global Corp (AVR) Expected Move
AVR expected move through Oct 16, 2026 is 19.3%, with 24 days to expiration. The implied range is $6.61 to $9.76, based on the previous trading day's options prices.
Read more
Tracking the AVR expected move helps you see how far Anteris Technologies Global Corp's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Anteris Technologies Global Corp's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the AVR expected move for this week's options, in real time.
The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For AVR, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The AVR expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Anteris Technologies Global Corp is unlikely to go.
Anteris Technologies Global Corp., a structural heart company, discovers, develops, and commercializes medical devices to enhance the quality of life for patients with aortic stenosis. Its lead product candidate is the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also devlops ADAPT anti-calcification tissue, an anti-calcification preparation that transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta.
Anteris Technologies Global Corp. was incorporated in 1999 and is based in Toowong, Australia.
Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the AVR expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Anteris Technologies Global Corp expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about AVR.
AVR Price
Drag chart to pan. Drag axes to zoom.
| Expiration | DTE | Expected move (USD) | Expected move (%) | Upper price | Lower price |
|---|---|---|---|---|---|
| Oct 16, 2026 | 24 | $1.58 | 19.3% | $9.76 | $6.61 |
| Nov 20, 2026 | 59 | $2.13 | 26.0% | $10.32 | $6.06 |
| Feb 19, 2027 | 150 | $3.38 | 41.4% | $11.57 | $4.81 |
| May 21, 2027 | 241 | $4.54 | 55.6% | $12.73 | $3.65 |
As of September 18, 2026
Know What the Market Expects From AVR
Track the AVR expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.
Start your 14-day free trial→